All articles tagged with #healthneuroscience
A study by the University of Turku found that high caffeine intake does not slow the progression of Parkinson's disease or improve its symptoms. Instead, it is linked to a greater decrease in dopamine transporter binding, likely due to a compensatory mechanism. Recent caffeine intake can also affect brain imaging results, suggesting patients avoid caffeine before testing.
Following the WVU Rockefeller Neuroscience Institute's feature on 60 Minutes for their research on using ultrasound to treat substance abuse disorder, they have received over 1500 inquiries from across the U.S. and five foreign countries. A dedicated team is responding to these inquiries, aiming to connect interested individuals with appropriate resources for clinical trials and research collaboration, with the goal of making the treatment more widely available in the future.
Research suggests that structural changes in neurons activate immune cells, leading to inflammation and reduced motor function in people with ALS. A study found that blocking inflammation with a semi-synthetic drug derived from the Ashwagandha plant can restore synaptic connections, offering a potential treatment for ALS and other inflammation-related diseases like Alzheimer’s. The findings provide insight into the correlation between neuron changes and immune responses, offering hope for new therapeutic approaches.